Finance

Lists
Why is GYRE up 18.70%?
Dive Deeper
GYRE:NASDAQ
Gyre Therapeutics Inc
$4.76
+18.70%
(+0.75) 1D
Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
$4.56
High
$4.79
Low
$4.08
Mkt. cap
504.72M
Avg. vol.
159.81K
Volume
359.72K
52-wk high
$9.14
52-wk low
$3.97
EPS
-$0.20
Beta
2.43
Shares outstanding
106.03M
No. of employees
625
Open
$4.56
High
$4.79
Low
$4.08
Mkt. cap
504.72M
Avg. vol.
159.81K
Volume
359.72K
52-wk high
$9.14
52-wk low
$3.97
EPS
-$0.20
Beta
2.43
Shares outstanding
106.03M
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
HeadquartersWinston-Salem, North Carolina, United States
SectorHealth Care
IndustryBiotechnology
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current $4.76
$20.00 (+320.17%)
Average
$19.00 (+299.16%)
Lowest
$18.00 (+278.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$18.00
+278.2%
11/06/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$20.00
+320.2%
08/10/2026
Roger Song
Jefferies
Buy
Initiated
$16.00
+236.1%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
37.20M
24.43M
29.10M
32.93M
Cost of goods sold
1.74M
1.23M
2.21M
1.95M
Cost of revenue
1.74M
1.23M
2.21M
-
Research and development expenses
4.82M
11.48M
19.14M
8.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.52M
24.31M
21.62M
23.95M
Operating expense
35.33M
35.79M
40.76M
32.46M
Total operating expenses
37.08M
37.02M
42.97M
34.40M
Operating income
120.00K
-12.59M
-13.86M
-1.47M
Other non operating income
-2.31M
244.00K
-811.00K
-
EBT including unusual items
-66.00K
-18.03M
-14.43M
-
EBT excluding unusual items
-864.00K
-11.65M
-13.93M
-1.70M
Income tax expense
1.30M
549.00K
-164.00K
-
Effective tax rate
-1,969.70%
-3.04%
1.14%
-42.01%
Other operating expenses
-
-
-
-
Net income
-1.72M
-10.30M
-10.60M
-4.05M
Net profit margin
-4.63%
-42.16%
-36.44%
-12.31%
Earnings per share
0.05
-
-
-
Interest and investment income
1.35M
743.00K
740.00K
588.00K
Interest expense
-
-
-
-
Net interest expenses
1.35M
743.00K
740.00K
588.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
815.00K
-11.92M
-12.38M
13.00K
Gain or loss from assets sale
2.00K
16.00K
2.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps